Cellnovo Group announced that Eric Beard will transition from CEO and Executive Chairman of the board of directors to Non-Executive Chairman, effective October 1. Mr. Beard has served as Chairman on the company's board of directors since 2011 and was appointed Executive Chairman in September 2012. As part of its executive succession plan, Cellnovo appointed Sophie Baratte as its CEO effective October 1, 2015. She has a distinguished career in healthcare having held senior positions at Johnson & Johnson, Sorin, CIT and Lifecell.

She has extensive experience in sales and marketing and particularly in bringing innovative technologies to market. Ms. Baratte joined Cellnovo in November 2014 as Chief Business Officer. She was appointed CEO of Cellnovo Ltd, the operations arm of the Group, in April 2015.

Cellnovo also announced the expansion of its management team with several new key hires: Myriam Desmetis appointed as Vice President Regulatory Affairs and Quality Affairs. For the past 3 years, Ms. Desmet was Senior Manager of the Clinical Safety for the international division at St. Jude Medical.

She also worked as head of the regulatory affairs and quality assurance for Kimberly-Clark Healthcare where she contributed to the registration of several medical devices across the world. Didier LeNormand joins Cellnovo as interim CFO in replacement of Bart Bergstein who has left the company. Mr. LeNormand has a long and distinguished career in banking and finance having worked for, among others, BASF, Leica and most recently Novagali Pharma.

Bommy Lee, is appointed as Director of Digital Marketing and Communications. Ms. Lee is a digital marketing professional who previously had developed the digital strategy and approaches for Mauna Kea Technologies. She has also worked at the International Herald Tribune as Senior Producer and Editor.

Thierry Lambert, is appointed as Director of Distributor Network for Cellnovo. Mr. Lambert joins Cellnovo from LabStyle. He has a strong experience of the diabetes field, acquired at Medtronic, and later at Dexcom where he launched their Continuous Blood Glucose device across Europe, driving both marketing and distribution strategies and partnerships.